Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
ZNTL - Zentalis Pharmaceuticals Inc - Stock Price Chart
TickerZNTL [NASD, RUT]
CompanyZentalis Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap293.98MEPS (ttm)-3.36
P/E-EPS this Y39.51%
Forward P/E-EPS next Y-34.28%
PEG-EPS past 5Y-50.05%
P/S7.25EPS next 5Y-
P/B0.64EPS Q/Q113.26%
Dividend-Sales Q/Q-
Insider Own12.31%Inst Own113.65%
Insider Trans-0.48%Inst Trans-0.93%
Short Float28.13%EarningsMay 07/b
Analyst Recom2.20Target Price12.11
Avg Volume653.22K52W Range8.25 - 30.53
Jun-18-24Downgrade Wells Fargo Overweight → Equal Weight
Jun-18-24Downgrade Wedbush Neutral → Underperform $15 → $4
Jun-18-24Downgrade Morgan Stanley Overweight → Equal-Weight $38 → $8
Jun-18-24Downgrade Jefferies Buy → Hold $42 → $6
Today 04:52AM FDA places partial clinical hold on Zentalis trials of azenosertib for cancer (Clinical Trials Arena)
Jun-18-24 07:00AM Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program (GlobeNewswire) -50.66%
Jun-03-24 06:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-01-24 02:43AM Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): President, Interim CFO Cam Gallagher ... (GuruFocus.com)
May-30-24 07:00AM Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-29-24 07:00AM Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors (GlobeNewswire)
May-23-24 05:01PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting (GlobeNewswire) -5.84%
May-14-24 07:00AM Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-08-24 10:27AM Stifel Adjusts Price Target on Zentalis Pharmaceuticals to $32 From $36, Maintains Buy Rating (MT Newswires)
May-07-24 09:04PM Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ... (GuruFocus.com) +5.03%
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap1.60MEPS (ttm)-9.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.26EPS next 5Y-
P/B-EPS Q/Q407.08%
Dividend-Sales Q/Q-
Insider Own21.91%Inst Own1.09%
Insider Trans0.00%Inst Trans-20.28%
Short Float13.85%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume1.16M52W Range2.12 - 74.40
Jun-18-24 08:19AM Why Is Aerwins Technologies (AWIN) Stock Down 54% Today? (InvestorPlace) -47.90%
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-29-24 07:39AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -38.73%
May-28-24 10:52PM AWIN Stock Earnings: AERWINS Technologies Reported Results for Q1 2024 (InvestorPlace) +143.09%
May-16-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -18.47%
May-15-24 02:31PM Is Aerwins Technologies (AWIN) Stock the Next Big Short Squeeze? (InvestorPlace) +131.73%
Apr-23-24 05:15PM AERWINS Technologies Announces Additional Staff Determination (GlobeNewswire) -5.13% -16.52%
Mar-28-24 11:25AM AERWINS Technologies Announces 1-For-100 Reverse Stock Split (GlobeNewswire) -12.90%
Dec-04-23 07:21AM 10 Best Debt Free Penny Stocks To Buy Now (Insider Monkey)
Oct-24-23 08:41AM Why Is Aerwins Technologies (AWIN) Stock Up 26% Today? (InvestorPlace) +8.51%
THMO - ThermoGenesis Holdings Inc - Stock Price Chart
TickerTHMO [NASD]
CompanyThermoGenesis Holdings Inc
CountryUSA
IndustryMedical Devices
Market Cap1.75MEPS (ttm)-4.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.10%
P/S0.18EPS next 5Y-
P/B1.79EPS Q/Q88.67%
Dividend-Sales Q/Q6.42%
Insider Own55.83%Inst Own2.24%
Insider Trans0.00%Inst Trans-48.53%
Short Float0.61%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume85.78K52W Range0.30 - 1.82
Jun-12-24 10:06AM FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts (InvestorPlace) -27.90%
08:39AM Why Is ThermoGenesis (THMO) Stock Down 37% Today? (InvestorPlace)
07:46AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jun-05-24 07:35AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -6.10%
May-17-24 10:52PM THMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +12.74%
Nov-14-23 10:26AM ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript (Insider Monkey) -17.85%
07:25AM Q3 2023 Thermogenesis Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 04:05PM ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire) +17.48%
Nov-08-23 08:31AM ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update (PR Newswire)
Oct-26-23 04:30PM ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento (PR Newswire)
HOLO - MicroCloud Hologram Inc - Stock Price Chart
TickerHOLO [NASD]
CompanyMicroCloud Hologram Inc
CountryChina
IndustryElectronic Components
Market Cap5.61MEPS (ttm)-1.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-483.40%
P/S0.19EPS next 5Y-
P/B0.28EPS Q/Q-320.24%
Dividend-Sales Q/Q-
Insider Own69.53%Inst Own1.20%
Insider Trans0.00%Inst Trans-98.39%
Short Float66.66%Earnings-
Analyst Recom-Target Price-
Avg Volume12.72M52W Range1.17 - 113.00
Jun-05-24 06:00AM The 3 Best Meme Stocks to Buy in June 2024 (InvestorPlace) -15.66%
Jun-01-24 07:04AM MicroCloud Hologram Outlook: Run for the Hills, HOLO Stock Investors! (InvestorPlace)
May-17-24 04:09PM Meme stock frenzy begins to fizzle (Yahoo Finance Video) +8.38% -7.49%
12:56PM These stocks ripped even higher than GameStop in the meme rally (Yahoo Finance)
May-14-24 11:25AM Is a Giant Short Squeeze Brewing in Faraday Future (FFIE) Stock? (InvestorPlace) +61.50%
10:55AM Why Is MicroCloud Hologram (HOLO) Stock Up 59% Today? (InvestorPlace)
07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Apr-18-24 08:11AM Why Is MicroCloud Hologram (HOLO) Stock Up 47% Today? (InvestorPlace) +31.70%
Mar-13-24 10:17AM Why Is MicroCloud Hologram (HOLO) Stock Up 31% Today? (InvestorPlace) +37.01%
Mar-06-24 06:20AM Danger, Danger! Don't Be Enticed by HOLO Stock's Hollow Victory. (InvestorPlace)
BFRG - Bullfrog AI Holdings Inc - Stock Price Chart
TickerBFRG [NASD]
CompanyBullfrog AI Holdings Inc
CountryUSA
IndustryHealth Information Services
Market Cap15.54MEPS (ttm)-0.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S222.04EPS next 5Y-
P/B2.28EPS Q/Q5.91%
Dividend-Sales Q/Q-
Insider Own58.77%Inst Own2.15%
Insider Trans-2.64%Inst Trans-
Short Float2.80%Earnings-
Analyst Recom-Target Price-
Avg Volume81.31K52W Range2.35 - 8.35
May-29-24 08:00AM Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12 (GlobeNewswire) -6.69%
May-16-24 08:00AM BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders (GlobeNewswire)
May-13-24 10:53AM BFRG Stock Earnings: Bullfrog AI Hldgs Reported Results for Q1 2024 (InvestorPlace)
May-03-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Apr-26-24 09:00AM BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Apr-09-24 08:00AM BullFrog AI's CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo (GlobeNewswire)
Mar-08-24 08:00AM BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute (GlobeNewswire) -8.49%
Feb-26-24 08:00AM BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer (GlobeNewswire) +17.69%
Feb-21-24 12:01PM BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock (GlobeNewswire)
Feb-09-24 08:00AM BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip (GlobeNewswire) +9.15%
CING - Cingulate Inc - Stock Price Chart
TickerCING [NASD]
CompanyCingulate Inc
CountryUSA
IndustryBiotechnology
Market Cap3.55MEPS (ttm)-23.91
P/E-EPS this Y92.08%
Forward P/E-EPS next Y-13.35%
PEG-EPS past 5Y-24.19%
P/S-EPS next 5Y-
P/B0.89EPS Q/Q91.51%
Dividend-Sales Q/Q-
Insider Own25.37%Inst Own1.89%
Insider Trans0.00%Inst Trans-73.16%
Short Float6.00%EarningsMay 08/b
Analyst Recom2.00Target Price20.00
Avg Volume216.28K52W Range0.65 - 21.20
May-21-24 09:00AM FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD (GlobeNewswire) +5.08%
May-08-24 01:54PM CING Stock Earnings: Cingulate Beats EPS for Q1 2024 (InvestorPlace)
07:00AM Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update (GlobeNewswire)
Apr-30-24 05:45AM Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-16-24 05:00PM Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024 (GlobeNewswire) +5.16%
Apr-01-24 08:00AM Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update (GlobeNewswire)
Mar-19-24 04:45PM Cingulate to Participate in Benzinga All Live Access Event (GlobeNewswire)
Mar-06-24 06:45AM Cingulate to Attend DCAT Week 2024 in New York City (GlobeNewswire)
Feb-13-24 06:45AM Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors (GlobeNewswire)
ARBB - ARB IOT Group Ltd - Stock Price Chart
TickerARBB [NASD]
CompanyARB IOT Group Ltd
CountryMalaysia
IndustryInformation Technology Services
Market Cap13.48MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own43.11%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.28%Earnings-
Analyst Recom1.00Target Price3.00
Avg Volume71.09K52W Range0.58 - 4.80
Feb-13-24 07:46AM Why Is ARB IOT (ARBB) Stock Up 230% Today? (InvestorPlace) +68.18%
Jul-05-23 06:55AM Is ARB IOT Group Limited's (NASDAQ:ARBB) 16% ROE Better Than Average? (Simply Wall St.)
Apr-25-23 01:40PM ARB IOT Group Limited Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering (GlobeNewswire) -11.04%
Apr-10-23 03:59PM ARB IOT Group Limited Announces Closing of $5.0 Million Initial Public Offering (GlobeNewswire)
Apr-04-23 07:15PM ARB IOT Group Limited Announces Pricing of $5.0 Million Initial Public Offering (GlobeNewswire)
SLRX - Salarius Pharmaceuticals Inc - Stock Price Chart
TickerSLRX [NASD]
CompanySalarius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap-EPS (ttm)-173.74
P/E-EPS this Y-597.92%
Forward P/E-EPS next Y12.31%
PEG-EPS past 5Y64.97%
P/S-EPS next 5Y-
P/B0.06EPS Q/Q81.69%
Dividend-Sales Q/Q-
Insider Own6.08%Inst Own-
Insider Trans0.00%Inst Trans-3.23%
Short Float-EarningsMay 09
Analyst Recom3.00Target Price26.00
Avg Volume17.87K52W Range3.09 - 12.48
Jun-17-24 08:00AM Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting (GlobeNewswire)
Jun-12-24 08:00AM Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split (GlobeNewswire)
May-13-24 10:53PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace) -7.12%
04:43PM Salarius: Q1 Earnings Snapshot (Associated Press Finance)
Mar-22-24 09:52PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace) +5.96% -17.74%
04:34PM Salarius: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 08:00AM Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses (GlobeNewswire)
Jan-16-24 08:00AM Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders (GlobeNewswire)
Jan-03-24 08:30AM Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals' Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment (GlobeNewswire)
CABA - Cabaletta Bio Inc - Stock Price Chart
TickerCABA [NASD, RUT]
CompanyCabaletta Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap403.14MEPS (ttm)-1.72
P/E-EPS this Y-29.17%
Forward P/E-EPS next Y-3.98%
PEG-EPS past 5Y-26.63%
P/S-EPS next 5Y-
P/B1.82EPS Q/Q-13.60%
Dividend-Sales Q/Q-
Insider Own13.60%Inst Own100.71%
Insider Trans-0.33%Inst Trans-19.25%
Short Float22.71%EarningsMay 15/b
Analyst Recom1.00Target Price33.56
Avg Volume1.22M52W Range9.25 - 26.35
Jun-14-24 02:00AM Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis and RESET-SLE Trials of CABA-201 (GlobeNewswire) -15.13%
May-29-24 08:00AM Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -5.81%
May-16-24 05:23PM Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-15-24 11:54AM CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024 (InvestorPlace) +13.00%
07:00AM Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-13-24 08:00AM Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Mar-23-24 05:31AM Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway (GuruFocus.com)
Mar-21-24 01:53PM CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023 (InvestorPlace)
07:00AM Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-20-24 07:00AM Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis (GlobeNewswire)
AMIX - Autonomix Medical Inc. - Stock Price Chart
TickerAMIX [NASD]
CompanyAutonomix Medical Inc.
CountryUSA
IndustryMedical Devices
Market Cap21.04MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.77EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own56.40%Inst Own0.18%
Insider Trans0.00%Inst Trans-
Short Float0.72%Earnings-
Analyst Recom-Target Price-
Avg Volume61.75K52W Range1.13 - 7.60
Jun-18-24 08:00AM Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire) -17.04%
Jun-17-24 04:05PM Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer (GlobeNewswire) -7.53%
Jun-10-24 08:00AM Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 (GlobeNewswire) -9.49%
Jun-06-24 09:00AM This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management (News Direct) -9.09%
Jun-03-24 02:52PM AMIX Stock Earnings: Autonomix Medical Reported Results for Q4 2024 (InvestorPlace) -10.53%
08:15AM Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
May-31-24 08:05AM Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +7.55%
May-23-24 09:15AM Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer (GlobeNewswire) -5.91%
May-14-24 04:15PM Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire)
Apr-25-24 08:30AM Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip (GlobeNewswire) +6.84%
123456⋯10⋯20
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.